Related Experiment Video
Updated: May 6, 2026
06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
35.3K
Tracking the clonal origin of lethal prostate cancer
The Journal of Clinical Investigation
|October 19, 2013
Summary
The lethal prostate cancer clone originated from a small, low-grade tumor focus, not the main tumor or lymph node metastasis. This highlights the need for molecular markers to predict lethal prostate cancer progression.
Area of Science:
- Oncology
- Genomics
- Pathology
Background:
- Prostate cancer overtreatment necessitates identifying molecular drivers of lethal metastatic disease.
- Understanding cancer evolution is crucial for accurate prognostication and treatment.
Observation:
- Whole-genome sequencing and molecular pathology were used to analyze the lethal cell clone in a fatal prostate cancer case.
- The study tracked the clone's evolution from primary tumor to metastases over time.
Findings:
- The lethal clone surprisingly originated from a small, low-grade focus within the primary tumor.
- It did not arise from the higher-grade primary tumor bulk or a resected lymph node metastasis.
Implications:
- Molecular prognostic markers (e.g., PTEN, p53 alterations) may improve pathological evaluation and reveal clonal heterogeneity.
- Longitudinal sampling of metastatic lesions is vital for precision medicine in advanced prostate cancer.
- Further studies are needed to assess the clinical management impact of clonal evolution in prostate cancer.
